Key result
Central obesity and family history linked to ~4.6-fold higher hypertension risk in T2D.
Why the study?
This study aimed to examine the joint effect of central obesity and family history of hypertension on hypertension in Chinese patients with type 2 diabetes mellitus.
Does the combination of central obesity and family history of hypertension synergistically increase the risk of hypertension in patients with type 2 diabetes?
Cross-Sectional (n=1,756)
Yes
Does the combination of central obesity and family history of hypertension synergistically increase the risk of hypertension in patients with type 2 diabetes?
Effect estimate: OR 4.64 (95% CI 3.22-6.67)
Central obesity and family history of hypertension have a synergistic additive effect on increasing the risk of hypertension in Chinese patients with type 2 diabetes.
Purpose: This study aimed to examine the joint effect of central obesity (CO) and family history of hypertension (FHH) on hypertension in Chinese patients with type 2 diabetes mellitus (T2DM). Methods: A total of 1756 T2DM patients were enrolled from a cross-sectional study conducted in Zhejiang Province, China (March - November 2018). Multivariate logistic regression models were used to analyze factors associated with hypertension and to assess CO-FHH interactions on both additive and multiplicative scales. Associations between waist circumference (WC) and systolic/diastolic blood pressure (SBP/DBP) were evaluated using generalized additive models (GAM) and Spearman correlation. The relationship between WC and hypertension was further explored using restricted cubic splines (RCS). Results: The prevalence of hypertension was 64.52%. WC was positively correlated with SBP (r = 0.25, P<0.001) and DBP (r=0.27, P<0.001), and showed a linear association with hypertension in both sexes (P for non-linearity>0.05). After adjusting for potential covariates, T2DM patients with both CO and FHH had a 4.64-fold higher risk of hypertension (95% CI: 3.22-6.67) compared to the reference group. A statistically significant additive interaction between CO and FHH was observed, with a relative excess risk due to interaction (RERI) of 1.59 (95% CI: 0.39-3.19), an attributable proportion (AP) of 0.34 (95% CI: 0.08-0.51), and a synergy index (SI) of 1.78 (95% CI: 1.13-2.79). No statistically significant multiplicative interaction was found. Conclusion: CO and FHH may jointly contribute to hypertension in Chinese T2DM patients through an additive effect beyond their individual associations. Maintaining a healthy WC is especially important for T2DM patients with a family history of hypertension.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) conducted a cross-sectional in Type 2 diabetes mellitus (n=1,756). Central obesity and family history of hypertension vs. No central obesity and no family history of hypertension was evaluated on Hypertension (OR 4.64, 95% CI 3.22-6.67). The combination of central obesity and a family history of hypertension was associated with a 4.64-fold higher risk of hypertension in patients with type 2 diabetes compared to having neither factor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: